Viewing StudyNCT00458705



Ignite Creation Date: 2024-05-05 @ 5:25 PM
Last Modification Date: 2024-10-26 @ 9:32 AM
Study NCT ID: NCT00458705
Status: COMPLETED
Last Update Posted: 2016-01-22
First Post: 2007-04-09

Brief Title: Bortezomib Doxorubicin Hydrochloride Liposome and Dexamethasone Followed by Thalidomide and Dexamethasone With or Without Bortezomib in Treating Patients With Multiple Myeloma
Sponsor: Memorial Sloan Kettering Cancer Center
Organization: Memorial Sloan Kettering Cancer Center

Conditions & Keywords Data

Conditions:
Name
Multiple Myeloma and Plasma Cell Neoplasm
Keywords:
Name View
stage I multiple myeloma View
stage II multiple myeloma View
stage III multiple myeloma View
refractory multiple myeloma View